Projects per year
Personal profile
Biography
I am a haematologist and haemato-oncologist, managing all blood disorders including general haematology, malignant haematology (eg lymphoma, leukaemia, myeloma), bleeding disorders, venous thromboembolic disease (blood clots) and obstetric haematology.
I am involved in clinical trials and translational research, with an interest in myelodysplastic syndrome (MDS), a pre-leukaemia disease, running Australia wide clinical trials in this condition.
The Blood Unit is a Specialist Haematology Group Practice at Cabrini, for more detailed information on our practice, please visit: http://www.thebloodunit.com.au/
Research area keywords
- Myelodysplastic syndrome
- Blood disorders
- Malignant Haematology
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
Kenealy, M. & Lai, L. H.
5/08/21 → 31/12/24
Project: Research
-
A phase III, multicenter, open-label, randomised study to evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (B-Pd) versus pomalidomide plus bortezomib and dexamethasone (PVd) in participants with relapsed/refractory multiple myeloma [207499] [DREAMM 8]
Kenealy, M. & Lai, L. H.
27/01/21 → 31/12/23
Project: Research
-
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia
McQuilten, Z. K., Busija, L., Seymour, J. F., Stanworth, S., Wood, E. M., Kenealy, M., Weinkove, R. & on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 23 Feb 2022, In: Leukemia and Lymphoma. 63, 3, p. 676-683 8 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients
Brooker, J., Julian, J., Millar, J., Prince, H. M., Kenealy, M., Herbert, K., Graham, A., Smith, R., Kissane, D., Taylor, K., Frydenberg, M., Porter, I., Fletcher, J., Haines, I. & Burney, S., Apr 2020, In: Palliative and Supportive Care. 18, 2, p. 130-140 11 p.Research output: Contribution to journal › Article › Research › peer-review
12 Citations (Scopus) -
Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy
Baird, S. M., Kenealy, M. K. & Hoy, R., 2 Nov 2015, In: Leukemia and Lymphoma. 56, 11, p. 3233-3235 3 p.Research output: Contribution to journal › Letter › Other › peer-review
4 Citations (Scopus) -
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy
Carney, D. A., Westerman, D. A., Tam, C. S., Milner, A., Prince, H. M., Kenealy, M., Wolf, M., Januszewicz, E. H., Ritchie, D., Came, N. & Seymour, J. F., Dec 2010, In: Leukemia. 24, 12, p. 2056-2062 7 p.Research output: Contribution to journal › Article › Research › peer-review
90 Citations (Scopus) -
Treatment-related myelodysplasia following fludarabine combination chemotherapy
Tam, C. S., Seymour, J. F., Prince, H. M., Kenealy, M., Wolf, M., Januszewicz, E. H. & Westerman, D., Nov 2006, In: Haematologica. 91, 11, p. 1546-1550 5 p.Research output: Contribution to journal › Article › Research › peer-review
68 Citations (Scopus)